Huanyu Ding

Huanyu Ding

Auto-generated profile, based on publicly available information

Huanyu Ding

School of Biomedical Sciences, Faculty of Medicine The Chinese University of Hong Kong Hong Kong China

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
HDHuanyu Ding
Huanyu Ding
YLYuan Liu
Yuan Liu
NXNianjin Xie
Nianjin Xie
RFRuixin Fan
Ruixin Fan
SLSongyuan Luo
Songyuan Luo
JLJianfang Luo
Jianfang Luo

1 November 2018 in Journal of Thoracic Disease
Verified
Journal Article
Closed access
PDF file
LXLing Xue
Ling Xue
SLSongyuan Luo
Songyuan Luo
HDHuanyu Ding
Huanyu Ding
YZYi Zhu
Yi Zhu
YLYuan Liu
Yuan Liu
JLJianfang Luo
Jianfang Luo
Background: Spinal cord ischemia (SCI) is a recognized grave complication after thoracic endovascular aortic repair (TEVAR). The present study aimed to evaluate the incidence and investigate risk of SCI after TEVAR based on current prophylactic strategies designed against established risk factors. Methods: The study retrospectively reviewed a prospectively maintained database to investigate patients who underwent TEVAR successfully between January 2009 and December 2012 in a single cardiovascular center. Detailed assessment of SCI risk was routinely performed for all patients before TEVAR was carried out. Prophylactic measures, including left subclavian artery (LSA) revascularization, blood pressure augmentation and cerebrospinal fluid (CSF) pressure control after TEVAR, were employed in high-risk patients and physical neurological examinations were regularly done to evaluate SCI after TEVAR. Patients were further divided into SCI group and non-SCI group. Results: A total of 650 patients were enrolled in the study. Eleven patients (1.69%) developed SCI after TEVAR. Baseline level of hemoglobin was significantly lower in the SCI group (113.00 vs. 128.50, P=0.023). More patients in the SCI patients in the SCI group underwent TEVAR under general anesthesia (45.5% vs. 17.7%, P=0.033). A significantly higher incidence of post TEVAR hypotension was found in the SCI group (2.7% vs. 27.3%, P=0.004). Logistic regression analysis revealed that post-TEVAR hypotension (OR, 8.379; 95% CI, 1.833–38.304; P=0.006) was strongly associated with development of SCI and high normal baseline hemoglobin was a protective factor (OR, 0.969; CI, 0.942–0.998; P=0.037). The mortality in hospital and mortality at 1 year were not significant different between the SCI and the non-SCI group (0% vs. 1.6% P=1.000; 9.1% vs. 3.0%, P=0.294, respectively). While length of post-TEVAR stay (13.00 vs. 7.00 days, P=0.000) and length of hospital stay (20.00 vs. 13.00 days, P=0.001) were significantly greater in the SCI group. Conclusions: Our study revealed that, based on current prophylactic measures to curtail SCI, including LSA revascularization, blood pressure augmentation and CSF pressure control after TEVAR, post-TEVAR hypotension remains a major and independent risk factor for SCI and high normal baseline hemoglobin level is protective. SCI results in longer post-TEVAR stay and hospital stay, but not associated with increased mortality. Robust precautions should be taken against underlying causes for post-TEVAR hypotension and low level of hemoglobin should be avoided.

19 February 2019 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Open access
PDF file
LXLing Xue
Ling Xue
SLSongyuan Luo
Songyuan Luo
HDHuanyu Ding
Huanyu Ding
YLYuan Liu
Yuan Liu
WHWenhui Huang
Wenhui Huang
RFRui-Xin Fan
Rui-Xin Fan
Background: This study aimed to investigate whether miR‐146a‐5p was involved in the pathogenesis of thoracic aortic dissection (AD) via regulating the biological function of vascular smooth muscle cells (VSMCs).Methods: Circulating miR‐146a‐5p level was measured by quantitative polymerase chain reaction (qPCR) in AD patients and healthy controls. Human dissected aortic samples were obtained from patients with thoracic AD Stanford type A undergoing surgical repair, and normal control samples were from organ donors who died from nonvascular diseases. The expression level of miR‐146a‐5p was detected using qPCR in each sample. The expression of SMAD4, which is involved in the TGF‐β pathway and indicated as the target gene of miR‐146a‐5p, was measured by qPCR and Western blot analysis at the mRNA level and protein level, respectively. Subsequently, VSMCs were transfected with miR‐146a‐5p mimics or inhibitors in vitro. VSMC proliferation and migration were detected using 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide and Transwell assay, respectively. Flow cytometry was used to identify apoptosis. The expression of SMAD4 in VSMCs was determined using qPCR and Western blot analysis.Results: Plasma level of miR‐146a‐5p is significantly higher in the AD group as compared with the control group. The expression of miR‐146a‐5p was significantly upregulated in dissected aorta compared with controls (P < 0.05). The overexpression of miR‐146a‐5p significantly induced VSMC proliferation and migration in vitro.Conclusions: The expression of SMAD4 was modulated by miR‐146a‐5p. miR‐146a‐5p induced VSMC proliferation and migration through targeting SMAD4 and hence might be potentially involved in the development of AD.

1 March 2018 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
HDHuanyu Ding
Huanyu Ding
SLSongyuan Luo
Songyuan Luo
YLYuan Liu
Yuan Liu
WHWenhui Huang
Wenhui Huang
MJMinchun Jiang
Minchun Jiang
JLJianfang Luo
Jianfang Luo

1 October 2019 in Clinical Interventions in Aging
Verified
Journal Article
Open access
PDF file
WHWenhui Huang
Wenhui Huang
HDHuanyu Ding
Huanyu Ding
MJMinchun Jiang
Minchun Jiang
YLYuan Liu
Yuan Liu
CHCheng Huang
Cheng Huang
ZJZhisheng Jiang
Zhisheng Jiang
Purpose: The goal of present study is to document our single-center experience with chimney technique for aortic arch diseases. Patients and methods: From August 2012 to October 2017, 226 patients (mean age 54±12 years; 197 men) with aortic arch diseases underwent thoracic endovascular aortic repair combined with chimney stents. The aortic stent-grafts were deployed in zone 0 (n=22), zone 1 (n=13), or zone 2 (n=191). Results: The technical success rate was 84% (189/226) and immediate type Ia endoleak (ELIa) happened in 37 (16%) patients. The 30-day mortality and morbidity rates were 2% (4/226) and 4% (8/226), respectively. Major adverse events include four major strokes, three spinal cord ischemia and one aortic rupture in the early-term. The clinical and imaging follow-up rates were 98% (218/222) and 78% (173/222), respectively. The average lengths of clinical and imaging follow-up were 22±16 months and 20±15 months, respectively. Chimney stent obstructions in left subclavian arteries were recorded in six (3%) patients. During follow-up, five patients died (2%) and two major strokes occurred (1%). One patient (0.5%) underwent reintervention. Conclusion: The current study documented that the chimney technique is effective and safe for treating aortic arch diseases in different aortic zones. Cautions are needed to assess the permanency of chimney stent and to reduce the immediate ELIa rate.

1 November 2015 in Medicine
Verified
Journal Article
Open access
ZLZilun Li
Zilun Li
HDHuanyu Ding
Huanyu Ding
ZSZhen Shan
Zhen Shan
JDJianliang Du
Jianliang Du
CYChen Yao
Chen Yao
SWShenming Wang
Shenming Wang
Symptomatic isolated dissection of the superior mesenteric artery (SIDSMA) represents an extremely rare condition. Although various treatments including conservative treatment, endovascular stenting (ES), and surgical repair are currently available, consensus treatment guideline is absent due to scarce of SIDSMA cases. Thus, we present our experience in the treatment of SIDSMA at our single center.Fourteen cases of SIDSMA were treated with conservative treatment, catheter-directed thrombolysis (CDT), endovascular stenting (ES), or surgical repair at our center between January 2008 and January 2014. Demographics, clinical manifestations, coexisting medical conditions, imaging feature, treatments, and follow-up outcome of these patients were retrospectively collected and analyzed.For 13 patients without peritonitis, conservative treatment was given for 4 to 6 days initially. After the first observation cycle, symptoms and signs were alleviated in 8 patients, and conservative treatments were continued. The remaining 5 patients received technically and clinically successful ES (in 4) or CDT (in 1) due to worsening symptoms and signs during conservative treatment. One patient with peritonitis underwent emergency surgery, with the necrotic small intestine resected. However, the abdominal pain was not alleviated 17 days postoperatively, ES was thus performed and symptoms relieved immediately. Two weeks after ES, a new aneurysm and partial thrombosis in the distal part of the stent were found by computed tomography angiography in this patient. No intestinal infarction or mortality developed during hospitalization. Follow-up was accomplished in 11 cases, ranging from 4 to 74 months (23.5 ± 21.3). Except that one complained with mild abdominal pain, the other 10 achieved complete remission. All patients were free from new aneurysmal formation of SMA and all stents remained patent.For SIDSMA without peritonitis, conservative treatment can be provided with reasonable success rate, while ES may serve as an effective alternative once conservative treatment fails. For SIDSMA with peritonitis, open surgery remains the treatment of choice by resection of necrotic intestine and revasculization.